Kras Status as Predictive Marker of Response and Time to...

Annals of Oncology 2012 / 09 Vol. 23

Kras Status as Predictive Marker of Response and Time to Progression in EGFR Wild-Type Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Platin-Docetaxel-Bevacizumab

Domine, M., Rojo, F., Izarzugaza, Y., Zazo, S., Lobo, F., Aceñero, M. Fernandez, Madoz, J., Casado, V., Rubio, G., Garcia-Foncillas, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
23
Journal:
Annals of Oncology
DOI:
10.1016/s0923-7534(20)32758-7
Date:
September, 2012
File:
PDF, 75 KB
2012
Conversion to is in progress
Conversion to is failed